PRESS RELEASE: Model Drug Law for West Africa presented to ministers of health on the sidelines of the 72nd session of the World Health Assembly

Télécharger la version française GENEVA, 22 May 2019—The West Africa Commission on Drugs, UNAIDS and the Global Commission on Drug Policy today presented the Model Drug Law for West Africa to ministers of health of the Economic Community of West African States. Drug laws in western Africa are not having

Continue reading

Press Release: The Global Commission welcomes Kgalema Motlanthe and Cassam Uteem as new members

Geneva, 27 March 2019 The Global Commission on Drug Policy is honored and delighted to welcome as distinguished new members, Kgalema Motlanthe, former President of South Africa (2008-2009), and Cassam Uteem, former President of Mauritius (1992-2002). Kgalema Motlanthe was politically active from an early age, serving in the ANC (African

Continue reading

Khalid Tinasti in Modern Ghana: “Africa’s Time To Shape International Drug Policy”

Read original article in Modern Ghana. Africa’s Time To Shape International Drug Policy Last March, during a discussion on the decriminalization of drug use at a diplomatic dinner in Vienna, where the United Nations’ drug control entities sit, a Central African representative said that “African countries cannot decriminalize, because only

Continue reading

Commissioner Kazatchkine on Africanews: “Débat sur la légalisation du cannabis en Afrique”

Commissioner Michel Kazatchkine gives the opinion of the Global Commission on Drug Policy on the failures of the prohibitionist regime of drug control land the need to legally regulate all drugs. Michel Kazachkine, membre de la Commission globale de politique en matière de drogues, présente la position de la Commission

Continue reading

BBC World Service: “Nigeria’s Obasanjo speaks out on drug policy”

The Global Commission on Drug Policy – a group of eminent world leaders – has called for a rethink on drugs policy. They’ve released a new report saying the current attitude of stigmatising drugs is hindering effective policy-making, and argue that governments should be talking about ‘harm reduction’ rather than

Continue reading